US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist

4.710
-0.140-2.89%

Close Mar 10 16:00 ET

4.662
-0.048-1.03%

Post 20:01 ET

274.67MMarket Cap-14.27P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vanda Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	52.25M	53.19M	+935.00K
Beat Est.	+15.42%	+17.48%	+1.79%
EPS	-0.11	-0.08	+0.03
Beat Est.	-175.44%	-100.00%	+27.21%

Analyst Rating

Buy

Feb 28, 2025

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 45.134M	--
May 3, 2023	2023/Q1	-- / 62.500M	--
Feb 13, 2025	2024/Q4	53.185M / 52.250M	--
Nov 6, 2024	2024/Q3	47.651M / 49.155M	--
Jul 31, 2024	2024/Q2	50.474M / 47.860M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 45.134M--

May 3, 20232023/Q1-- / 62.500M--

Feb 13, 20252024/Q453.185M / 52.250M--

Nov 6, 20242024/Q347.651M / 49.155M--

Jul 31, 20242024/Q250.474M / 47.860M--

Unlock Free Earnings Estimates

Open Account

Vanda Pharmaceuticals Earnings Reports

Vanda Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 14 16:43 ET

Vanda Pharmaceuticals | 8-K: Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 13 16:13 ET

Vanda Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:13 ET

Vanda Pharmaceuticals | 8-K: Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024 16:22 ET